French-Italian team headed by researchers from CNRS and Inserm (1) has recently discovered a new family of compounds that could make it possible to treat numerous cancers, particularly brain tumours and skin cancers.
Ewing sarcoma is a rare paediatric bone cancer. However, this condition occurs more frequently in populations of European ancestry.
(French) À l’occasion de la journée mondiale contre le cancer, l’Association pour la Recherche sur le Cancer (ARC) l’Inserm et l’Institut national de cancer (INCa) présentent un web documentaire intitulé "Recherche sur les cancers : tout s’accélère".
The expression of p53 and Mdm2 is closely related. In an article published this week in the Cancel Cell review, Robin Fahraeus and his collaborators from Inserm Unit 940 (“Therapeutic Targets for Cancer”), demonstrate that cellular response to DNA damage requires involvement from the protein kinase ATM so that Mdm2 can positively or negatively control protein p53. […]